Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04469049 · ClinicalTrials.gov registry record · NA
MBCT for People With Parkinson's Disease and Caregivers
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT04469049 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 28 participants.
The verdict
NCT04469049, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
This study aims to explore the feasibility and effectiveness of mindfulness-based cognitive therapy (MBCT) in reducing anxiety and/or depressive symptoms in people with Parkinson's disease (PD) and caregivers of people with PD.
Interventions
- BEHAVIORAL Mindfulness-based cognitive therapy (MBCT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2020-11-11 |
| Est. Completion | 2021-06-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04469049
The ClinicalTrials.gov registry entry for NCT04469049 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mindfulness-based cognitive therapy (MBCT) is the first listed.
NCT04469049 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04469049 about?
NCT04469049 is a clinical study titled "MBCT for People With Parkinson's Disease and Caregivers". This study aims to explore the feasibility and effectiveness of mindfulness-based cognitive therapy (MBCT) in reducing anxiety and/or depressive symptoms in people with Parkinson's disease (PD) and caregivers of people with PD.
What is the current status of trial NCT04469049?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2020-11-11. Estimated completion is 2021-06-11.
What interventions are being tested in trial NCT04469049?
The interventions under investigation include: Mindfulness-based cognitive therapy (MBCT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04469049?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.